A primary mission at FDA?s center for biologics evaluation and research is to protect and advance public health by ensuring the safety and efficacy of therapeutic proteins, including plasma…

Ended Awarded Last action

Contract number
75F40121F19078
Awardee
Awarding agency
Obligated
$102,240

Award facts

Contract value 100% obligated
$102,240.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Available for Competition Only One Source
Pricing
Labor Hours
Place of performance
Silver Spring, MD 20993, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00003 -$2,000
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $104,240

About this award

This is a delivery order contract awarded by the Food and Drug Administration (FDA) to Midnight Sun Technologies LLC, a subsidiary of Kikiktagruk Inupiat Corporation (KIC) - an Alaska Native Corporation. The $102,240 contract supports the FDA's Center for Biologics Evaluation and Research in protecting and advancing public health through ensuring the safety and efficacy of therapeutic proteins, including plasma protein-based therapies used for COVID-19 infection. This is a labor hours contract type with a November 15, 2022 completion date. As an 8(a) Program participant and Indian Economic Enterprise, Midnight Sun Technologies leverages its small business status to provide scientific, technical, and business support services to federal agencies like the FDA and National Institutes of Health (NIH). Midnight Sun Technologies also holds several significant Indefinite Delivery Vehicles (IDVs) with the FDA and Department of the Interior Bureau of Indian Affairs, valued up to $25 million each.

Description

A primary mission at FDA?s center for biologics evaluation and research is to protect and advance public health by ensuring the safety and efficacy of therapeutic proteins, including plasma protein-based therapies used for COVID19 infection. To suppo

Quick answers

Who was awarded contract 75F40121F19078?

75F40121F19078 was awarded to Midnight Sun Technologies LLC by Food and Drug Administration (Department of Health and Human Services) on September 16, 2021.

How much is contract 75F40121F19078 worth?

The government has obligated $102,240 on 75F40121F19078.

Is contract 75F40121F19078 an order under another contract?

Yes. 75F40121F19078 is a delivery order under 75F40119D10015, an indefinite delivery contract.

Was contract 75F40121F19078 competed?

The extent of competition for 75F40121F19078 was not available for competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award